Recent studies have caused researchers to become concerned that patients who take certain drugs to treat their diabetes have an increased risk of developing cancer of the pancreas. The drugs at issue are Januvia, Victoza, Byetta, and Onglyza, among others. These drugs are used to control blood sugar in patients with Type 2 diabetes. They do this by increasing insulin production by the pancreas and slowing absorption of food. Research has shown that these drugs can cause inflammation of the pancreas as well as pre-cancerous changes to cells in the pancreas. This can lead to changes in the tissue of the pancreas which can trigger the development of pancreatic cancer. If you or a loved one have developed pancreatic cancer and take or have taken drugs to treat diabetes, please contact us.
Related Posts
- May 1, 2024
- 0
- 172
EPA Addresses Legacy Asbestos…
EPA Addresses Legacy Asbestos Risks The Environmental Protection Agency (EPA) has taken significant steps in addressing the risks associated with legacy uses of asbestos. In a newly released draft risk…
Read more
- April 19, 2024
- 0
- 6325
Norfolk Southern Agrees to…
Norfolk Southern Agrees to Pay $600 Million in Settlement Related to Train Derailment in East Palestine, Ohio Norfolk Southern has agreed to pay $600 million in a class action lawsuit…
Read more
- April 17, 2024
- 0
- 6881
Mesothelioma Victims in Libby,…
Mesothelioma Victims in Libby, Montana Seek Justice Libby, Montana has struggled with a decades-long saga of asbestos contamination, a relentless ordeal leaving behind a trail of devastation. For decades, the…
Read more